| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
| Pulse Biosciences, Inc Common Stock (DE) | $1.5b | $24.59 | -9.3% | 570.7K | |
| Arbutus Biopharma Corporation Common Stock | $0.8b | $4.24 | -2.5% | 1.4M | |
| Rani Therapeutics Holdings, Inc. Class A Common Stock | $86.6m | $1.09 | -1.8% | 994.0K | |
| Clene Inc. Common Stock | $68.9m | $7.14 | +1.3% | 151.6K | |
| Zentek Ltd. Common Stock | $48.3m | $0.68 | -32.4% | 728.9K | |
| Polyrizon Ltd. Ordinary Shares | $30.9m | $15.20 | +1.2% | 27.5K | |
| NanoViricides Inc. | $26.1m | $1.41 | -19.1% | 622.5K | |
| Lexaria Bioscience Corp. Common Stock | $21.9m | $0.62 | +1.0% | 43.8K | |
| TransCode Therapeutics, Inc. Common Stock | $7.7m | $7.20 | +6.1% | 6.4K | |
| Aspire Biopharma Holdings, Inc. Common Stock | $1.0m | $5.94 | +1.2% | 117.0K |